Proteros biostructures
Services and technologies for x-ray structure analysis, kinetic screening and fragment-based drug discovery.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD31—47m (Dealroom.co estimates Aug 2007.)
Company register number HRB 121476 (München)
Planegg Bavaria (HQ)
Financials
Estimates*
EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|---|
EBITDA | 1.6m | 3.0m | 2.1m | 3.3m | 6.9m | 8.0m | - |
Profit | <1m | 1.3m | <1m | 1.6m | 4.1m | 4.1m | 7.3m |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Spinout | ||
€5.2m | Early VC | ||
€410k | Grant | ||
* | N/A | Growth Equity VC | |
Total Funding | CAD8.4m |
Recent News about Proteros biostructures
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.